Agostino Consoli

18.0k total citations · 1 hit paper
165 papers, 6.7k citations indexed

About

Agostino Consoli is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Agostino Consoli has authored 165 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Endocrinology, Diabetes and Metabolism, 58 papers in Molecular Biology and 43 papers in Physiology. Recurrent topics in Agostino Consoli's work include Diabetes Treatment and Management (51 papers), Metabolism, Diabetes, and Cancer (43 papers) and Diabetes Management and Research (33 papers). Agostino Consoli is often cited by papers focused on Diabetes Treatment and Management (51 papers), Metabolism, Diabetes, and Cancer (43 papers) and Diabetes Management and Research (33 papers). Agostino Consoli collaborates with scholars based in Italy, United States and Germany. Agostino Consoli's co-authors include N. Nurjhan, John E. Gerich, F Capani, Assunta Pandolfi, Gloria Formoso, Kenneth Cusi, Ralph A. DeFronzo, Giovanni Davı̀, Giovanni Ciabattoni and Andrea Mezzetti and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

Agostino Consoli

160 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Vivo Formation of 8-Iso-Prostaglandin F_2αand Platelet Activation in Diabetes Mellitus

1999 617 citations Giovanni Davı̀, Agostino Consoli et al. profile →

Peers

Countries citing papers authored by Agostino Consoli

Since Specialization

Citations

This map shows the geographic impact of Agostino Consoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agostino Consoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agostino Consoli more than expected).

Fields of papers citing papers by Agostino Consoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agostino Consoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agostino Consoli. The network helps show where Agostino Consoli may publish in the future.

Co-authorship network of co-authors of Agostino Consoli

This figure shows the co-authorship network connecting the top 25 collaborators of Agostino Consoli. A scholar is included among the top collaborators of Agostino Consoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agostino Consoli. Agostino Consoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long‐Term Effectiveness of Once‐Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real‐World Study 2025 ·Diabetes/Metabolism Research and Reviews ·Benedetta Maria Bonora, Andrea Giaccari, Agostino Consoli, Fabio Broglio, Angelo Avogaro, Gian Paolo Fadini, (unknown)	0
2	GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 2024 ·Acta Diabetologica ·Stefano Ciardullo, Mario Luca Morieri, (unknown), Teresa Vanessa Fiorentino, Teresa Mezza, Domenico Tricò, Agostino Consoli, Stefano Del Prato, Francesco Giorgino, Salvatore Piro, Anna Solini, Angelo Avogaro	9
3	Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment 2024 ·Journal of Clinical Medicine ·(unknown), Giulia Di Dalmazi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marco Giorgio Baroni, Agostino Consoli, Gloria Formoso	7
4	IDegLira for the real‐world treatment of type 2 diabetes in Italy. Final results from the REX observational study 2024 ·Diabetes Obesity and Metabolism ·Gian Paolo Fadini, Raffaella Buzzetti, Dario Pitocco, (unknown), Alessia Scatena, Olga Lamacchia, (unknown), Lucia Simoni, Agostino Consoli, (unknown)	4
5	Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journey 2023 ·Nutrition Metabolism and Cardiovascular Diseases ·Concetta Irace, (unknown), Graziano Di Cianni, (unknown), Francesco Landi, Maria Rosaria Rizzo, Giorgio Sesti, Elena Succurro, Agostino Consoli	6
6	Unmet clinical need e nuovi farmaci 2022 ·Recenti Progressi in Medicina ·(unknown), (unknown), (unknown), Agostino Consoli, Filippo de Braud, (unknown), (unknown), Massimo Riccaboni, Giuseppe Rossi, (unknown), (unknown), Pierluigi Viale, Claudio Jommi, Patrizia Popoli	1
7	Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss 2022 ·Cardiovascular Diabetology ·Paola Simeone, Romina Tripaldi, Annika E. Michelsen, Thor Ueland, Rossella Liani, (unknown), Kåre I. Birkeland, Hanne L. Gulseth, Augusto Di Castelnuovo, Francesco Cipollone, Pål Aukrust, Agostino Consoli, Bente Halvorsen, Francesca Santilli	10
8	Health care organization and use of technological devices in people with diabetes in Italy: Results from a survey of the Working Group on Diabetes and Technology 2022 ·Nutrition Metabolism and Cardiovascular Diseases ·Dario Pitocco, Andrea Laurenzi, L. Tomaselli, Roberta Assaloni, Agostino Consoli, Paolo Di Bartolo, Vincenzo Guardasole, Fortunato Lombardo, Claudio Maffeis, Antonio Rossi, Rosaria Gesuita, Sergio Di Molfetta, Andrea Rigamonti, Andrea Scaramuzza, Concetta Irace, Valentino Cherubini	9
9	Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 2022 ·Nutrition Metabolism and Cardiovascular Diseases ·Paola Simeone, Rossella Liani, Giuseppina Bologna, Romina Tripaldi, Augusto Di Castelnuovo, Pasquale Simeone, Damiano D’Ardes, Sebastianó Miscia, Francesco Cipollone, Marco Marchisio, Agostino Consoli, Paola Lanuti, Francesca Santilli	2
10	Old and New Biomarkers Associated with Endothelial Dysfunction in Chronic Hyperglycemia 2021 ·Oxidative Medicine and Cellular Longevity ·(unknown), Caterina Pipino, Assunta Pandolfi, Agostino Consoli, Natalia Di Pietro, Gloria Formoso	6
11	Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes 2021 ·Nutrition Metabolism and Cardiovascular Diseases ·(unknown), Paola Simeone, Giovambattista Desideri, Rossella Liani, Romina Tripaldi, (unknown), Armando Tartaro, Maria Teresa Guagnano, Augusto Di Castelnuovo, Francesco Cipollone, Agostino Consoli, Francesca Santilli	7
12	Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 2020 ·International Journal of Obesity ·(unknown), Paola Simeone, Andrea Boccatonda, Maria Teresa Guagnano, Rossella Liani, Romina Tripaldi, Augusto Di Castelnuovo, Francesco Cipollone, Agostino Consoli, Francesca Santilli	83
13	Comparative effectiveness of dapagliflozin vs DPP‐4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world 2020 ·Diabetes/Metabolism Research and Reviews ·Mario Luca Morieri, Agostino Consoli, Giorgio Sesti, Francesco Purrello, Angelo Avogaro, Gian Paolo Fadini, (unknown)	14
14	In vivo thromboxane‐dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 2019 ·Diabetes/Metabolism Research and Reviews ·Francesca Santilli, Francesco Zaccardi, Rossella Liani, Giovanna Petrucci, Paola Simeone, Dario Pitocco, Romina Tripaldi, Alessandro Rizzi, Gloria Formoso, Alfredo Pontecorvi, (unknown), Francesca Pagliaccia, (unknown), (unknown), Ester Vitacolonna, Bianca Rocca, Agostino Consoli, Carlo Patrono	13
15	Glucagon‐like peptide‐1 receptor agonists in type 2 diabetes treatment: are they all the same? 2018 ·Diabetes/Metabolism Research and Reviews ·R. Gentilella, V. Pechtner, (unknown), Agostino Consoli	181
16	Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 2017 ·Diabetes Care ·Francesca Santilli, Paola Simeone, Maria Teresa Guagnano, (unknown), (unknown), Augusto Di Castelnuovo, (unknown), Riccardo C. Bonadonna, (unknown), (unknown), Stefano Cianfarani, Lamberto Manzoli, Giovanni Davı̀, Armando Tartaro, Agostino Consoli	83
17	Ridurre il rischio cardiovascolare nel trattamento del paziente diabetico: cos’è cambiato dagli anni ’90 ad oggi nell’approccio clinico? 2014 ·Giornale italiano di cardiologia ·Agostino Consoli, (unknown)	2
18	Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes 2014 ·Nutrition Metabolism and Cardiovascular Diseases ·Patrizia Di Fulvio, Assunta Pandolfi, Gloria Formoso, Sara Di Silvestre, Pamela Di Tomo, Annalisa Giardinelli, Alessandro De Marco, Natalia Di Pietro, (unknown), Silvia Sancilio, Roberta Di Pietro, Mauro Piantelli, Agostino Consoli	59
19	Correction: Magnetic Resonance Imaging Determined Visceral Fat Reduction Associates with Enhanced IL-10 Plasma Levels in Calorie Restricted Obese Subjects 2013 ·PLoS ONE ·Gloria Formoso, (unknown), Maria Teresa Guagnano, (unknown), Natalia Di Pietro, Armando Tartaro, Agostino Consoli	1
20	Il controllo glicemico intensivo nel diabete di tipo 2: è dannoso, superfluo e forse utile nella riduzione del rischio cardiovascolare? 2010 ·Giornale italiano di cardiologia ·Agostino Consoli	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact